期刊文献+

创伤后肘关节异位骨化研究进展 被引量:10

RESEARCH PROGRESS OF HETEROTOPIC OSSIFICATION OF ELBOW JOINT AFTER TRAUMA
原文传递
导出
摘要 目的综述创伤后肘关节异位骨化研究进展。方法查阅近年国内外有关创伤后肘关节异位骨化相关研究文献,并进行总结分析。结果创伤后肘关节异位骨化发生机制主要与BMP信号转导失调有关。目前临床对其治疗方法较多,包括非手术治疗、预防以及手术治疗。非手术治疗及预防主要针对创伤后肘关节未形成异位骨化或异位骨化致肘关节活动轻度受限的患者,包括药物治疗、放射治疗、中医中药治疗、康复治疗等。对于非手术治疗无效的患者,需选择手术治疗。手术治疗主要包括切开松解术、关节镜下松解术以及关节置换,其中以切开松解术为主。结论肘关节异位骨化临床常见,目前尚无一种公认的标准治疗方案,综合使用非手术治疗和手术治疗方案是今后治疗方向。 Objective To summarize the research progress of heterotopic ossification of the elbow joint after trauma. Methods The recent domestic and foreign literature concerning heterotopic ossification of the elbow joint after trauma was analysed and summarized. Results The mechanism of heterotopic ossification of the elbow joint after trauma is mainly related to bone morphogenetic protein signal transduction disorder. Now there are many treatments of heterotopic ossification, including non-surgical treatment, prevention, and surgical treatment. Non-surgical treatment and prevention mainly aim at patients who have no elbow heterotopic ossification or who have mild limited elbow motion because of elbow heterotopic ossification after trauma, including drug therapy, radiation therapy, Chinese medicine therapy, and rehabilitation treatment. For patients with invalid non-surgical treatment, choosing surgical treatment is a must. Surgical treatment includes surgical resection, arthroscopic resection, and joint replacement, priority should be given first to surgical resection. Conclusion Heterotopic ossification of the elbow joint is common and there is not a recognized standard treatment, comprehensive use of non-surgical treatment and surgical treatment is the future direction.
出处 《中国修复重建外科杂志》 CAS CSCD 北大核心 2015年第6期777-782,共6页 Chinese Journal of Reparative and Reconstructive Surgery
关键词 肘关节 异位骨化 创伤 Elbow Joint Heterotopic ossification Trauma
  • 相关文献

参考文献72

  • 1Thompson HC 3rd, Garcia A. Myositis ossificans: aftermath of elbow injuries. Clin Orthop Relat Res, 1967, (50): 129-134.
  • 2Keschner MT, Paksima N. The stiff elbow. Bull NYU Hosp Jt Dis, 2007, 65(1): 24-28.
  • 3Tannous O, Stall AC, Grittith C, et al. Heterotopic bone formation about the hip undergoes endochondral ossification" a rabbit model. Clin Orthop Relat Res, 2013, 471(5): 1584-1592.
  • 4Isaacson BM, Brown AA, Brunker LB, et al. Clarifying the structure and bone mineral content of heterotopic ossification. J Surg Res, 2011, 167(2): e163-170.
  • 5Kaplan FS, Glaser DL, Hebela N, et al. Heterotopic ossification. J Am Acad Orthop Surg, 2004, 12(2): 116-125.
  • 6Wozney }M. The bone morphogenetic protein family:multifunctional cellular regulators in the embryo and adult. Eur J Oral Sci, 1998, 106 Suppl 1: 160-166.
  • 7Shore EM, Xu M, Feldman GJ, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressive. Nat Genet, 2006, 38(5): 525- 527.
  • 8Chauveau C, Devedjian JC, Blary MC, et al. Gene expression in human osteoblastic cells from normal and heterotopic ossification. Exp Mol Pathol, 2004, 76(1): 37-43.
  • 9Rodenberg E, Azhdarinia A, Lazard ZW, et al. Matrix metalloproteinase-9 is a diagnostic marker of heterotopic ossification in a murine model. Tissue Eng Part A, 2011, 17(19-20): 248742496.
  • 10Lounev VY, Ramachandran R, Wosczyna MN, et al. Identification of progenitor cells that contribute to heterotopic skeletogenesis, l Bone Joint Surg (Am), 2009, 91(3): 652-663.

二级参考文献27

共引文献30

同被引文献55

引证文献10

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部